Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales (2016 - 2025)

Historic Return on Sales for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.0%.

  • Aytu Biopharma's Return on Sales fell 100.0% to 0.0% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.01% for FY2025, which is 600.0% up from last year.
  • Aytu Biopharma's Return on Sales amounted to 0.0% in Q4 2025, which was down 100.0% from 0.0% recorded in Q3 2025.
  • Aytu Biopharma's 5-year Return on Sales high stood at 0.02% for Q3 2024, and its period low was 2.2% during Q1 2022.
  • Its 5-year average for Return on Sales is 0.4%, with a median of 0.06% in 2023.
  • In the last 5 years, Aytu Biopharma's Return on Sales tumbled by -12300bps in 2021 and then surged by 18900bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Return on Sales (Quarter) stood at 0.5% in 2021, then soared by 49bps to 0.25% in 2022, then soared by 82bps to 0.04% in 2023, then surged by 117bps to 0.01% in 2024, then crashed by -76bps to 0.0% in 2025.
  • Its last three reported values are 0.0% in Q4 2025, 0.0% for Q3 2025, and 0.0% during Q2 2025.